Wells Fargo
TMCI icon

Wells Fargo’s Treace Medical Concepts TMCI Stock Holding History

Wells Fargo’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-55,300
Closed -$1.39M – 7698
2023
Q1 		$1.39M Buy
+55,300
New +$1.3M ﹤0.01% 3148

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wells Fargo's TMCI Position: Q1 2026 in Review

Wells Fargo reduced its Treace Medical Concepts (TMCI) stake by 66% in Q1 2026, selling an estimated $69K and leaving 17,543 shares worth $23.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5714.

Wells Fargo first reported a position in TMCI in Q2 2021 and has held it in 20 quarters since. The position peaked at $3.05M in Q3 2021. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • Wells Fargo held 17,543 shares of Treace Medical Concepts worth $23.5K as of Q1 2026.
  • Wells Fargo sold 34,620 Treace Medical Concepts shares in Q1 2026, an estimated $69K.
  • Treace Medical Concepts made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5714 holding.
  • Wells Fargo first reported a position in Treace Medical Concepts in Q2 2021 and has held it in 20 quarters since.
  • Wells Fargo's Treace Medical Concepts position peaked at $3.05M in Q3 2021.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.